
Article 1 
Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex.
Article 2 

1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
2. It shall apply from 1 December 2018 except that, to the extent that paragraph 2 of the Annex applies to the substance ‘formaldehyde … %’, that paragraph shall apply from the date of entry into force.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 2 May 2018.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:

((1)) Column 1 of entries 28 to 30 is replaced by the following:
'
28. Substances which are classified as carcinogen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 1 or Appendix 2, respectively.
29. Substances which are classified as germ cell mutagen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 3 or Appendix 4, respectively.
30. Substances which are classified as reproductive toxicant category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 5 or Appendix 6, respectively.'
((2)) In Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:
'
2,3-epoxypropyl methacrylate;glycidyl methacrylate 607-123-00-4 203-441-9 106-91-2 
cadmium carbonate 048-012-00-5 208-168-9 513-78-0 
cadmium hydroxide; cadmium dihydroxide 048-013-00-0 244-168-5 21041-95-2 
cadmium nitrate; cadmium dinitrate 048-014-00-6 233-710-6 10325-94-7 
formaldehyde … % 605-001-00-5 200-001-8 50-00-0 
anthraquinone 606-151-00-4 201-549-0 84-65-1 
N,N′-methylenedimorpholine;N,N′-methylenebismorpholine;[formaldehyde released from N,N′-methylenebismorpholine];[MBM] 607-721-00-5 227-062-3 5625-90-1 
reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2);[formaldehyde released from 3,3′-methylenebis[5-methyloxazolidine];formaldehyde released from oxazolidin];[MBO] 612-290-00-1 — — 
reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1);[formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol];[HPT] 612-291-00-7 — — 
methylhydrazine 612-292-00-2 200-471-4 60-34-4 '
((3)) In Appendix 4, the following entries are inserted in the table in order of the index numbers set out therein:
'
cadmium carbonate 048-012-00-5 208-168-9 513-78-0 
cadmium hydroxide; cadmium dihydroxide 048-013-00-0 244-168-5 21041-95-2 
cadmium nitrate; cadmium dinitrate 048-014-00-6 233-710-6 10325-94-7 '
((4)) In Appendix 6, the following entries are inserted in the table in order of the index numbers set out therein:
'
2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 606-041-00-6 400-600-6 71868-10-5 
2,3-epoxypropyl methacrylate;glycidyl methacrylate 607-123-00-4 203-441-9 106-91-2 
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol 650-032-00-X — 94361-06-5 
dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)]stannane 050-030-00-3 201-039-8 77-58-7 
nonadecafluorodecanoic acid; [1]ammonium nonadecafluorodecanoate; [2]sodium nonadecafluorodecanoate [3] 607-720-00-X 206-400-3 [1]221-470-5 [2][3] 335-76-2 [1]3108-42-7 [2]3830-45-3 [3] 
triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol 613-322-00-7 259-537-6 55219-65-3 
quinolin-8-ol;8-hydroxyquinoline 613-324-00-8 205-711-1 148-24-3 
thiacloprid (ISO);(Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide;{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide 613-325-00-3 — 111988-49-9 
carbetamide (ISO);(R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate 616-223-00-7 240-286-6 16118-49-3 '
